People 2000: National Health Promotion and Disease Prevention Objectives, 1 a report on some 300 national health objectives for the year 2000. Based on the input of scientists and health professionals in many fields, PHS set specific numerical targets that are thought to be achievable over the next decade and identified data to track progress toward these targets. As experience with the earlier 1990 Objectives for the Nation2 has shown, tracking these objectives can help to identify areas of success as well as areas that need more attention and resources. Thus the objectives will help guide health policy over the next decade.
The objectives are organized into 22 "priority areas" relating to specific problems, conditions, or diseases; risk factors; or potential interventions (see Table 1 ). Each priority area presents objectives for particular health status measures, for reduction of risk factors, and for provision of health services and protective measures. In total, the report contains about 300 objectives for the general population plus more for minority groups and other populations of special concern.
The objectives bring to bear in a specific and quantitative way the informed judgment ofpublic health experts on a critical demographic issue, future improvements in mortality and morbidity. The objectives were developed by groups of scientists and public health professionals who are aware of the currently available and soon-to-be available public health interventions. Therefore, they represent a wealth of information about both future mortality and morbidity in the United States and the potential for health promotion and disease prevention interventions.
The objectives were, however, written by many independent committees and appear in a number of different formats. Some objectives target improvements in specific causes of mortality and morbidity but use noncomparable or nonstandard measures to provide a baseline. Other objectives specify potential changes in risk factors, use of preventive services, and other implementation strategies, and they are not directly translated into mortality or morbidity measures.
The intent of this paper is to organize and analyze in demographic terms the potential for future reductions in mortality and morbidity implicit in the national objectives. Specifically, we calculate the impact on life expectancy and other summary demographic measures of meeting the targets set in the objectives. This analysis serves two purposes. First, it summarizes in quantitative terms the scientific and medical knowledge of the many experts who participated in setting the objectives. This should be of interest to demographers and forecasters who want a stronger scientific backing for their future mortality and morbidity projections. Second, it offers guidance for enhancing further efforts in health promotion and disease prevention. The analysis shows where the potential for health status improvements is high and low and thus in-Demogrphk Impact ofYear 2000 Objeces forms discussions about setting priorities among the objectives.
Meods
A number oftechnical features ofobjectives development should be taken into account in trying to develop measures of the overall mortality impact ofmeeting the objectives.
Because the objectives were drafted by 21 different working groups, the statistical measures used lack the unity of method that they would have if they had been developed by demographers and statisticians. Among mortality measures, for instance, nonstandard cause-of-death categories, rather than the categories used in vital statistics reports3 and Health, United States 1989, 4 are used for coronary heart disease, diabetes, pneumonia and influenza, and a number of specific kinds of injuries.
One of the hallmarks of the national objectives process is that it sets specific numerical targets for the future. This allows policymakers to assess progress in mid-decade and to redirect efforts in areas where we are falling behind. The groups drafting the objectives had varying approaches to setting targets, including (1) detailed demographic models of the impact of changes in risk factors and the use of preventive services on disease incidence and mortality, (2) simple and sophisticated statistical trend analyses, and (3) eyeballing the most recent data points in conjunction with educated guesswork. Because of the different methods used, some of the targets-specifically, those for coronary heart disease and unintentional injuries-look somewhat optimistic or conservative when compared to each other and to mortality trends.
The analysis in this paper focuses primarily on the mortality objectives, a small fraction of the total set of objectives. The objectives address many other health status concems-such as the incidence or prevalence of specific diseases, disabilities, or other conditions-as well as present targets for risk factor reductions and improvements in the provision of preventive services. Because they were expressed in so many different ways, we were not able to incorporate most of the morbidity and disability measures into a common framework. We were, however, able to incorporate a single objective adDemographic Framewor* In order to sum up the demographic impact of achieving the mortality objectives by the year 2000, we had to translate the objectives developed by PHS into a common framework for demographic calculations. As shown in Table 2 , we developed a cause-of-death list that is a compromise between the specific measures used in the objectives (and the prevention relevance that they represent) and the standard groupings from the Intemational Classification of Diseases, Ninth Revision (ICD-9)5 used to reportvital statistics. The 1987 death rates for these causes of death serve as the base for our calculations.
Infant mortality is included in the list, even though it is not a single cause of death, because the measure appears prominently in Healthy People 20001 and is frequently cited in health policy discussions. Pneumonia and influenza are grouped in a residual category, Other Causes, for which there are no objectives or the objectives cannot be translated to appropriate death rates.
To translate the mortality measures in the objectives into a common set of cause-specific death rates, we assumed that the annual rate of change implied by comparing the baseline figure and the target applied to the change in death rates from 1987 to 2000 for standard ICD groups.
One category in Table 2 , heart disease, has a residual that represents the part of the category that is not covered by the target of any specific objective, primarily because prevention efforts are thought to be significant only for the heart disease deaths due to coronary heart disease. Together the heart disease residual and the overall residual made up 10% of total deaths in 1987. For heart disease and dressing overall activity limitation into a comprehensive measure of mortality and disability. The 1970 starting point was chosen arbitrarily. The 1979 starting point corresponds to the implementation of ICD-9 in the United States, and in some cases changes between ICD-8 and ICD-9 cause major discontinuities in the data. For some causes of death PHS based the target on a trend analysis starting after 1979; for those causes we considered the additional trend line in establishing high and low mortality variants. For chronic obstructive pulmonary disease (COPD) the trend in the death rate is increasing, and we assumed a zero rate of change for the low mortality alternative. Table 2 shows the annual rate of change for the high and low mortality projections for each cause of death.
Calculation of Summary Mortaly Measures
We present our results in terms of standard life table parameters eo (life expectancy at birth), 165 (the probability of surviving to age 65), and 165 (life expectancy at age 65). Further calculations suggest that the major qualitative conclusions regarding mortality are seen in these measures alone. The calculations were done as follows.
We started with the age-and causespecific rates for 1987,6 using the following age ranges: 0, 1, 5(10)85. For each cause we then applied the relative annual rate of change from Table 2 Demogaphic Impact ofYear 2000 Objecives rates. All of the rates of change in Table 2 are for the total population.
In order to consolidate these calculations on the impact of changes in mortality with a targeted reduction in disability, we adapted methodology developed by Sullivan8 and used by others9"10 that allows us to estimate an expectation of life free ofdisability. The 
Resut
We have calculated the effect of meeting the objectives on overall mortality and on life expectancy without limitation in major activity, examined the impact of meeting specific objectives and groups of objectives on overall mortality and on the distribution of causes of death, and carried out an in-depth exploration of the specific targets chosen for coronary heart disease and unintentional injuries. 
Overa1l Mortality
The effect of meeting the mortality objectives on overall life expectancy is shown in Figure 2 . Depending on which of the two trend variants is used, the increase in life expectancy at birth by the year 2000 can range from 1.6 to 3.6 years. Although the trends based on data from the 1980s are not the least optimistic for every cause of death, they are in most cases. If trends based only on the more recent data were assumed, the increase in life expectancy at birth by the year 2000 would be about 1.7 years. Figure 2 also 
Years without Limitations in Major Activity
With current mortality and disability statistics, an average of 66.8 years out of 75.1-89% of life expectancy at birthwould be spent free of limitation in major activity. Ifthe target rate for major activity limitation is achieved, however, the number of years without limitation will increase to 69.3 to 69.7 years-approximately 90% of total life expectancydepending on the assumption about trends in nontargeted causes of death as above. The scenario that produces the largest increase in total life expectancy also produces the largest increase in disability-free life. That same scenario, however, also results in the greatest remaining number of years with activity limitation (7.5 years) because relatively more people survive to the older ages at which disability is most prevalent.
Under current conditions, an average of 13.2 disability-free years would be experienced after age 65-about 77% of the life expectancy at that age. Assuming that the year 2000 objectives are met, the number of disability-free years experienced af- and would all tend to benefit from any increases in the accessibility of clinical preventive services for any one of them.13 Therefore, we decided to look at the potential for reducing mortality for all chronic diseases. Similarly, since risk factors for injury deaths would tend to run together, we will also look at intentional and unintentional injuries taken together.
Infant mortality is itself a combination of causes of death at ages under 1 year, and the final category is the combination of pneumonia and influenza with the residual "other," which includes AIDS and other infectious diseases. Figure 3 and Table 3 23.6-24 .6%. COPD also increases, from 3.6% of deaths to 5.3-5.6%.
The smaller shares for heart disease and stroke are nearly canceled out by the larger shares for cancer and COPD, leading to little overall change in the proportion of deaths from chronic diseases.
Reevaluation ofHeart Disease and Injury Targets
Further analysis shows that the targeted reductions in heart disease and un-Demogaphic hnpad ofYear 2000 Objecte intentional injuries are less than the trends would predict. Figure 4 , for instance, shows trends in coronary heart disease since 1972. (As used in Healthy People 20001 and elsewhere by PHS, coronary heart disease refers to specific ICD codes within the broader category ofDiseases of the heart.15) Depending on which years are used for trend analysis, the projected death rate for the year 2000 is either 90.8 or 92.6 per 100 000. The target is set conservatively at 100 per 100 000, although the trend data suggest that 90 per 100 000 might be a more reasonable level. Figure 5 and Table 4 show that changing the target to 90 per 100 000 would have a major impact on the gain in eo (an additional increase of about 0.3-0.4 years) and in 165 (an additional increase of 0.3-0.4 percentage points). It would also affect the proportion ofdeaths due to heart disease and to chronic diseases. Assuming 1987 rates, 36.9% of all deaths are due to diseases of the heart. The percentage would fall to 29.5-32.4% with the new target. With the original heart disease target, this drop would only be to 31.8-34.6%. Similarly, the proportion of all deaths due to chronic diseases with 1987 rates is 72.7% and would fall to 69.6-70.4%. With the original heart disease target, this drop would only be to 70.5-71.2%. Figure 5 and Table 4 also show the impact of a change in the target for unintentional injury mortality. A report has shown that accident mortality of all types has fallen by 21% between 1979 and 1989.16 This rate ofchange is about double that called for in the PHS objectives. Changing the target from 29.3 to 22.0 per 100 000, consistent with the 10-year trend, would lead to a 0.2-0.3 year increase in life expectancy at birth and a 0.3-0.4 percentage point increase in the probability ofsurviving to age 65. The proportion of deaths due to all injurieswould drop from 6.1% to 4.9-5.1% of all deaths.
Taken together, lowering both the heart disease and unintentional injury targets would increase overall life expectancy at birth by 0.6 years to 77.2-77.8 years. The probability of surviving to age 65 would increase by 0.6-0. Figure 6) . Trends in the causespecific death rates used in this paper suggest an increase of 1.6-3.6 years to 76. Figure  6 shows, meeting the targets with the changes in the coronary heart disease and unintentional injury targets suggested above would put overall life expectancy above the middle of these ranges. plete information on the effect on health status ofchanges in risk factors and use of preventive services. Progress in expanding the discussion beyond mortality alone depends on the development of consistent, systematic, and timely measures of health status, risk factors, and preventive services. Data from the annual NHIS are used for many of the objectives, and with changes in the objectives and the survey a more integrated system might be achievable.
Erickson and her colleagues have suggested that composite health status measures that incorporate morbidity, disability, and quality of life could be obtained from the NHIS, and that these could be the basis for the calculation of a measure of quality-adjusted life years (QALY) that is analogous to life expectancy except that each year of life is discounted by the average "quality of life" people experience at that age. 19 To the extent that the year 2000 objectives for the prevalence of specific conditions relate to the measures that go into the QALY calculation, the impact of meeting those objectives could be summed up in the same way we have done here for objectives on mortality levels.
Because the PHS objectives are generally stated in terms ofoverall death rates without specific mention of age or sex patterns, we assumed for this analysis that the same percentage change applied to all age-specific death rates and did not differentiate by sex. The current pattems ofrisk reduction and use of preventive services probably do not result in the same percentage reductions in death rates at all ages, as we were forced to assume.
Clearly, further analysis needs to be used using more complex models of mortality decline than the ones we have used. Manton and his colleagues20 and Olshansky,21 for instance, have investigated the impact of delaying the progression of chronic diseases, not reducing their incidence.
Making the link between changes in risk factors and preventive services to health status measures will require two things. First, we need more extensive epidemiological studies on the prevalence of risk factors and the effect of changes in risk factors and preventive services on a full range of health status measures. Furthermore, preventive interventions must be carefully evaluated so that their population impact can be better understood. Second, more extensive demographic and epidemiological modeling efforts are needed to bring this information together so that the impact of changes in risk fac- tors and access to clinical preventive services can be better predicted. There is some work in this area that could be drawn on,2-27 but generally for one disease or risk factor at a time, and it is difficult to integrate this information.
Models of this sort can also shed light on the age-specific impact of preventive interventions that is lacking in this analysis. Manton, for instance, argues that risk factors and mortality reductions have a vety different relationship at older ages than they do at younger ages.28 Two kinds of issues need to be explored. First, detailed studies ofthe actual patterns ofmortality reductions would lead to a fuller understanding of the demographic impact of meeting the year 2000 objectives. Second, we need to explore the impact of interventions targeted at different age groups and thus get a better idea about the most effective way to manage health promotion and disease prevention interventions. E
